Anna Kakizaki
Podiatrist · Auburn, MANPI 1942839170
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Kairos Surgical Inc at 29.6% of the total. Reporting peaked in 2022 at $2,862 and has fallen 99.4% since, to $18 in 2025.
Across 39 payments — averaging $106.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$1K
- Orthofix Medical, Inc.$831
- Treace Medical Concepts, Inc.$684
- Johnson & Johnson$414
- Integra Lifesciences Corporation$377
- Stryker$256
- plus $363 from 7 others
What the payments were for
- Travel & lodging$1,45635%
- Food & beverage$1,49536%
- Education$1,20029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 2 | $1,227 |
| Orthofix Medical, Inc. | 3 | $831 |
| Treace Medical Concepts, Inc. | 6 | $684 |
| Johnson & Johnson | 6 | $414 |
| Integra Lifesciences Corporation | 7 | $377 |
| Stryker | 5 | $256 |
| Smith+Nephew | 3 | $201 |
| Bioventus LLC | 2 | $39 |
| Life Spine, Inc. | 1 | $34 |
| Axogen | 1 | $27 |
| Medtronic | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Bone Support Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$799
- Lapiplasty System$602
- INTEGRA$433
- INTEGRA DERMAL REGENERATION TEMPLATE$144
- PRIMATRIX$144
- PRIME SERIES$113
- GRAFIX PL$113
- STRAVIX PL$113
- TENOGLIDE TENDON PROTECTOR SHEET$113
- NEURAGEN NERVE GUIDE$113
- Fibulink$104
- ELITE$104
- NA$104
How this compares
$4,151 in reported general payments places this provider in the 80th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 121 | $1,875 |
| Ammonium Lactate | 68 | $881 |
| Meloxicam | 29 | $87 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $72 |
| Cephalexin | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Auburn
- Georgios PonirosAuburn$2K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.